Literature DB >> 7136757

Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats.

J O Jansson, K Albertsson-Wikland, S Edén, K G Thorngren, O Isaksson.   

Abstract

The effect of frequency of growth hormone (GH) administration on longitudinal bone growth and body weight was studied in hypophysectomized rats. Replacement therapy with 3 different doses of human GH [(hGH) Crescormone] was started 10-14 days after hypophysectomy and was continued for 5 days. Longitudinal bone growth, as measured by the tetracycline method, and body weight were determined during the injection period. With a daily replacement dose of 128 micrograms of hGH body weight gain and longitudinal bone growth were significantly higher when the hormone was injected 4 and 8 times per day compared with animals receiving the hormone in one daily injection. When the dose of hGH was 32 or 8 micrograms per day, longitudinal bone growth and body weight gain were more pronounced in animals receiving the hormone 2 and 4 times per day compared with animals receiving the hormone one or 8 times per day. The results of the present study demonstrate that the frequency of GH administration influence body growth. The findings suggest that the secretory pattern of GH influence the growth rate under in vivo condition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7136757     DOI: 10.1111/j.1748-1716.1982.tb06980.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

1.  Long-term GH treatment of GH-deficient adults: comparison between one and two daily injections.

Authors:  C Höybye; M Rudling
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

Review 2.  Optimization of growth hormone therapy in growth hormone deficient children.

Authors:  S M De Muinck Keizer-Schrama
Journal:  Indian J Pediatr       Date:  1991 Sep-Oct       Impact factor: 1.967

3.  The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.

Authors:  Y J Janssen; M Frölich; F Roelfsema
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

4.  Growth responses to patterned GH delivery.

Authors:  R G Clark; D Mortensen; L M Carlsson; D Carmignac; I Robinson
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

5.  Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice.

Authors:  J O Jansson; S Ekberg; S B Hoath; W G Beamer; L A Frohman
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450.

Authors:  D J Waxman; N A Pampori; P A Ram; A K Agrawal; B H Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

7.  Comparison of pulsatile vs. continuous administration of human placental growth hormone in female C57BL/6J mice.

Authors:  Shutan Liao; Mark H Vickers; Angharad Evans; Joanna L Stanley; Philip N Baker; Jo K Perry
Journal:  Endocrine       Date:  2016-08-11       Impact factor: 3.633

8.  Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.

Authors:  Andrew L Lewis; Faron Jordan; Tina Patel; Kirk Jeffery; Gareth King; Martin Savage; Stephen Shalet; Lisbeth Illum
Journal:  J Clin Endocrinol Metab       Date:  2015-10-01       Impact factor: 5.958

9.  Rising maternal circulating GH during murine pregnancy suggests placental regulation.

Authors:  Kathryn L Gatford; Beverly S Muhlhausler; Lili Huang; Pamela Su-Lin Sim; Claire T Roberts; Johannes D Velhuis; Chen Chen
Journal:  Endocr Connect       Date:  2017-04-12       Impact factor: 3.335

10.  A Body Weight Sensor Regulates Prepubertal Growth via the Somatotropic Axis in Male Rats.

Authors:  John-Olov Jansson; Adria Dalmau Gasull; Erik Schéle; Suzanne L Dickson; Vilborg Palsdottir; Anders Palmquist; Ferran Font Gironès; Jakob Bellman; Fredrik Anesten; Daniel Hägg; Claes Ohlsson
Journal:  Endocrinology       Date:  2021-06-01       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.